Skip to main content
TrialFinder
TrialFinder is for informational purposes only and does not provide medical advice. Always talk to your doctor about whether a trial is right for you.
RECRUITINGINTERVENTIONAL

VGAIT for Chemotherapy-induced Peripheral Neuropathy

Video-Guided Acupuncture Imagery Treatment in Chemotherapy-induced Peripheral Neuropathy

Important: This information is not medical advice. Talk to your doctor about whether a clinical trial is right for you.

About This Trial

Perform a feasibility study on imagined acupuncture treatment of Chemotherapy-induced peripheral neuropathy (CIPN)

Who May Be Eligible (Plain English)

Who May Qualify: - at least 18 years of age - have diagnosed by tissue sample (biopsy-confirmed) stage I-III breast cancer, - have completed adjuvant taxane-based chemotherapy (alone or in combination), , - have an Eastern Cooperative Oncology Group performance status of 0 or 1, and reported grade 1 or greater CIPN symptoms for more than 2 weeks as defined by the National Cancer Institute (NCI) Common Terminology Criteria for Adverse Events (CTCAE), version 4.03. Who Should NOT Join This Trial: - concurrent chemotherapy (there were no limitations on time from the last paclitaxel administration), - having metastatic or recurrent disease, - history of preexisting peripheral neuropathy prior to chemotherapy, - uncontrolled seizure disorder, - unstable cardiac disease or myocardial infarction within 6 months prior to study entry, being pregnant or nursing, or having used acupuncture for CIPN within 6 months prior to study entry. Always talk to your doctor about whether this trial is right for you.

Original Eligibility Criteria

View original clinical language
Inclusion Criteria: * at least 18 years of age * have histologically confirmed stage I-III breast cancer, * have completed adjuvant taxane-based chemotherapy (alone or in combination), , * have an Eastern Cooperative Oncology Group performance status of 0 or 1, and reported grade 1 or greater CIPN symptoms for more than 2 weeks as defined by the National Cancer Institute (NCI) Common Terminology Criteria for Adverse Events (CTCAE), version 4.03. Exclusion Criteria: * concurrent chemotherapy (there were no limitations on time from the last paclitaxel administration), * having metastatic or recurrent disease, * history of preexisting peripheral neuropathy prior to chemotherapy, * uncontrolled seizure disorder, * unstable cardiac disease or myocardial infarction within 6 months prior to study entry, being pregnant or nursing, or having used acupuncture for CIPN within 6 months prior to study entry.

Treatments Being Tested

OTHER

Video-Guided Acupuncture Imagery Treatment (VGAIT)

Participants watch a video of acupuncture being applied to the body while simultaneously imagining that it is being administered to them

Locations (1)

Massachusetts General Hospital
Charlestown, Massachusetts, United States